Related Articles
An oncolytic herpes simplex virus vector, G47Δ, synergizes with paclitaxel in the treatment of breast cancer
A novel oncolytic herpes simplex virus armed with the carboxyl-terminus of murine MyD116 has enhanced anti-tumour efficacy against human breast cancer cells
SOCS4 expressed by recombinant HSV protects against cytokine storm in a mouse model
Oncolytic recombinant herpes simplex virus for treatment of orthotopic liver tumors in nude mice
The oncolytic herpes simplex virus vector G47∆ effectively targets breast cancer stem cells